Test-Retest of (18)F-Fluoroazomycin Arabinoside ([18F]FAZA) PET-CT of Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03168737

Title field or adapter rule

{'original_value': 'Test-Retest of (18)F-Fluoroazomycin Arabinoside ([18F]FAZA) PET-CT of Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:23.799813+00:00

Published At

2026-10-08T00:00:00+00:00

Record Updated At

2026-10-08

Source Retrieved At

2026-10-31T22:17:52.415050+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Malignant Breast Neoplasm", "Malignant Colorectal Neoplasm", "Malignant Pancreatic Neoplasm", "Malignant Solid Neoplasm"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-08", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT03168737"

protocolSection.identificationModule.officialTitle

"Test-Retest of (18)F-Fluoroazomycin Arabinoside ([18F]FAZA) PET-CT of Solid Tumors"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Malignant Breast Neoplasm (protocolSection.conditionsModule.conditions)
• Malignant Colorectal Neoplasm (protocolSection.conditionsModule.conditions)
• Malignant Pancreatic Neoplasm (protocolSection.conditionsModule.conditions)
• Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Group A (18F-fluoroazomycin arabinoside, PET-CT scans)', 'Group B (18F-fluoroazomycin arabinoside, PET-CT scans)'], 'description': 'Undergo PET-CT scan', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Group A (18F-fluoroazomycin arabinoside, PET-CT scans)', 'Group B (18F-fluoroazomycin arabinoside, PET-CT scans)'], 'description': 'Given IV', 'name': 'Fluorine F 18-fluoroazomycin Arabinoside', 'type': 'RADIATION'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Group A (18F-fluoroazomycin arabinoside, PET-CT scans)', 'Group B (18F-fluoroazomycin arabinoside, PET-CT scans)'], 'description': 'Undergo PET-CT scan', 'name': 'Positron Emission Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.